BridgeBio Pharma, Inc.
$76.60
-2.08 (-2.64%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -6.7%
- 3 Months
- +15.6%
- YTD
- +0.1%
- 1 Year
- +54.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 47.3%
- Largest decline max drawdown, since Aug 2025
- -20.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.15
Own BBIO?
See how BBIO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.